Highlights
ASX: NEU       NEUREN PHARMACEUTICALS LIMITED
Last Price Today's Change   Day's Range   Trading Volume
2.48   -0.08 (3.12%)  2.41 - 2.70  122,606

Overview

 
Avg Volume (4 weeks):123,658
4 Weeks Range:1.815 - 2.70
4 Weeks Price Volatility (%):
75.14%
52 Weeks Range:0.98 - 2.70
52 Weeks Price Volatility (%):
87.21%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Neuren Pharmaceuticals Limited (Neuren) is a biopharmaceutical company engaged in developing drugs for neurological disorders. The Company develops therapies for brain injury, neurodevelopmental and neurodegenerative disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. Its products include NNZ-2566 and NNZ-2591. Its lead product, NNZ-2566 (Trofinetide), is in Phase II trial for the treatment of Rett syndrome, Fragile X syndrome, moderate to severe Traumatic Brain Injury (TBI) and Concussion. Trofinetide is an analog of a molecule, which is derived from insulin-like growth factor-1 (IGF-1) and occurs naturally in the brain. Its NNZ-2591 product is in Pre-clinical and Phase I trial for the treatment of other neurological conditions. Its subsidiaries include Hamilton Pharmaceuticals Inc. and Neuren Pharmaceuticals Inc.

  Be the first to like this.
 


 

549  831  961  2028 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SCG 3.87-0.14 
 SRO 0.0020.00 
 88E 0.0140.00 
 NVO 0.0150.00 
 BLK 0.012+0.001 
 ACW 0.04+0.002 
 LPD 0.019+0.001 
 TLS 3.59-0.02 
 BLY 0.0070.00 
 S32 2.50+0.04 
Partners & Brokers